NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma

Baishu Zheng1, Shunde Wang2, Xiaoyu Yuan1

  • 1Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong district, Chongqing, 400010, China.

BMC Urology
|May 3, 2023
PubMed
Abstract

Insights

NUF2 is upregulated in clear cell renal cell carcinoma (ccRCC) tissues, correlating with poor prognosis and increased immune infiltration. This suggests NUF2 may be a therapeutic target for ccRCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Clear cell renal cell carcinoma (ccRCC) is a prevalent malignancy.
  • Immunotherapy shows promise for metastatic ccRCC.
  • NUF2, a component of the Ndc80 complex, influences cell proliferation and apoptosis.

Purpose of the Study:

  • Investigate the role of NUF2 in ccRCC.
  • Elucidate the underlying mechanisms of NUF2 in ccRCC progression.

Main Methods:

  • Analyzed NUF2 mRNA expression in ccRCC tissues using TCGA and GEO databases.
  • Correlated NUF2 expression with clinicopathologic variables and overall survival.
  • Assessed NUF2's relationship with tumor immune infiltration using GEPIA and TIMER databases.
  • Performed functional enrichment and protein-protein interaction analyses.

Main Results:

  • NUF2 mRNA expression was significantly upregulated in ccRCC tissues.
  • Elevated NUF2 expression correlated with advanced pathological stage, lymph node metastasis, and poorer prognosis.
  • NUF2 positively associated with tumor immune cell infiltration and immune cell markers.
  • NUF2 and its related genes are implicated in cell cycle and mitosis regulation.

Conclusions:

  • NUF2 is upregulated in ccRCC and associated with poor prognosis.
  • NUF2 plays a role in ccRCC immune infiltration.
  • NUF2 may serve as a potential prognostic biomarker and therapeutic target for ccRCC.